Looking for a U Turn, last PR's have been positive, the dividends are still in play along with the S1 NGIO shares. This is what could happen if an FDA Approval hits as an example: https://ih.advfn.com/stock-market/NASDAQ/amarin-AMRN/stock-news/81354740/amarin-receives-fda-approval-of-vascepa-icosapent